Flagship on center stage: Axcella’s new CMO likens the biotech to ‘professional sports team’; Life after the FDA takes shape for Stephen Hahn as a chief executive

Margaret Koziel

Margaret Koziel has bounced back and forth between academia and biotech throughout her career — and after 25 years, she has landed her first position as part of a biotech’s top brass.

Koziel joined Axcella Therapeutics — founded by Flagship’s Noubar Afeyan, Geoffrey von...

Click to view original post